New ACMG Guidance on Carrier Screening: More or Less Equitable?
ELSI Friday Forum • December 10, 2021
Next-generation sequencing capabilities have enhanced general population carrier screening by expanding the number of genes and variants on carrier screening panels. Professional recommendations are shifting towards universal screening, that is: screening that is not limited to populations by race or ethnicity and more inclusive of diverse populations. While this may lead to increased and wider accessibility to genetic information, these recommendations continue to face a number of scientific, ethical and social challenges that may undermine the goal of health equity. Who has access to carrier screening? Who should receive carrier testing and why? On what basis are decisions about the “severity of genetic conditions” being determined, by whom, and at what cost? And, what role should communities that are impacted by carrier screening guidelines have in these discussions? This session will explore carrier screening from a historical and clinical perspectives and consider the tradeoffs of increased detection and uncertainty, utility, and disability inclusion.
Panelist: Blair K. Stevens, MS, CGC (University of Texas Health)
Panelist: Katie Stoll, MS, CSC (Genetic Support Foundation)
Moderator: Maya Sabatello, LLB, PhD (Columbia University)
Please see the attached transcript and resources files in the upper right hand corner of this page for more information on this topic, as well as the ELSIhub Collection "Expanded Carrier Screening (ECS): Clinical and Ethical Considerations for Genetic Counseling"
Tags
Videos in Series
-
ELSI Friday Forum - The Genomics of PTSD Risk: Scientific and Ethical Perspectives
-
ELSI Friday Forum - Population Descriptors in Genomic Research: Applying the NASEM Recommendations
-
ELSI Friday Forum - Legal and Policy Challenges to Privacy in the Post-Genomic and Post-Dobbs Era
-
ELSI Friday Forum - Value and Values in Payment for Gene Therapies
-
ELSI Friday Forum - Visual Storytelling in ELSI Research
-
ELSI Friday Forum - Indigenizing Genomics and Advancing Indigenous Data Sovereignty
-
ELSI Friday Forum - Wrestling with Social and Behavioral Genomics
-
ELSI Friday Forum - Genetic Advantages in Sports: When Do They Count as "Doping"?
-
ELSI Friday Forum - Genetics and AI: Group Privacy and Fairness
-
ELSI Friday Forum - Advocacy and Allyship in ELSI: Opportunities and Challenges
-
ELSI Friday Forum - Decoloniality and Genetic Ancestry: Situating the "African Genome"
-
ELSI Friday Forum - Legal Challenges to Newborn Screening Research
-
ELSI Friday Forum - Impact of SCOTUS's Dobbs Decision on Prenatal Genomics Research and Practice
-
ELSI Friday Forum - Addressing Algorithmic Harms: Practices and Provocations for Health AI
-
ELSI Friday Forum - Balancing Data Privacy and Data Sharing: Normative and Technical Approaches
-
ELSI Friday Forum - Genomic Imaginaries: Sparking Dialogue between ELSI and Literary Studies
-
ELSI Friday Forum - Ensuring Equitable Use of New Genetic Technologies: Lessons from Eugenics
-
ELSI Friday Forum - Benefit-sharing and Pharmaceutical Development in Africa: What Does Equity Mean?
-
ELSI Friday Forum - Genomic Data Sharing: Putting Principles and Policy into Practice
-
ELSI Friday Forum - Current Legal Challenges to Abortion: Implications for Prenatal Genetics
-
ELSI Friday Forum - Ethical Challenges in Novel Gene Therapies for Sickle Cell Disease
-
ELSI Friday Forum - Widening the Lens: Using Arts in ELSI Research
-
ELSI Friday Forum - Migrant DNA: Context, Ethics and Legal Issues
-
ELSI Friday Forum - Genomics and Infectious Disease: Scientific and ELSI Issues of COVID
-
ELSI Friday Forum - ELSI Friday Forum: Biobanking in the Era of COVID
-
ELSI Friday Forum - Addressing Racism in Research and Clinical Practice
-
ELSI Friday Forum - ELSI Friday Forum: Structural Racism and Genomics in the Time of COVID